...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trillium

Toinv

 

I would have to say THE BOD on both RVX and Zenith are not doing there fidiciary duty to maximize shareholder value  over the past 10 years , I wonder why??  I will give a simple answer IMO ..... Maybe the BOD on both companies are full of insiders who prefer to keep the SP low  and valuation  low in order to build higher equity positions ownership at the lowest price possible.  IMO this is being done by design by the insiders , ie Hepa,  Ori star etc,  DM is a puppet to their demands, and keeping their finances going for both companies.   I don't why they can't bring in the right  management team to build a company simialr to the like of Trilluim and Repare Therapeutics , . A change in management or addition  would give instant  credilbility and branding that woudld bring alot new shareholders ,and a higher SP

Share
New Message
Please login to post a reply